The study also sought to identify the impact of anthracycline therapy on heart function and reveals the therapy poses dangerous heart problems to cancer patients because it not only affects the heart function directly but also weakens the ability of the heart do adapt other ‘stressors’ later in the life for example, a major operation, pregnancy and chest radiotherapy. Dr. Zhang thereforenotes that clinicians should closely monitor the heart function of cancer patients before and after chemotherapy.
